Polycystin 1/PC1 Antibody [B20F13]

Catalog No.: F2579

    Application: Reactivity:

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:200
    Application
    IHC
    Source
    Mouse Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years

    Datasheet & SDS

    生物学的記述

    Specificity
    Polycystin 1/PC1 Antibody [B20F13] detects endogenous levels of total Polycystin 1/PC1 protein.
    Clone
    B20F13
    Synonym(s)
    Polycystin‑1; PC1; Autosomal dominant polycystic kidney disease 1 protein; PKD1
    Background
    Polycystin 1 (PC1), encoded by the PKD1 gene, is a large transmembrane protein that functions as a mechanosensitive receptor in epithelial cells of renal tubules, liver, and pancreas, where it regulates cell–matrix adhesion, lumen architecture, and mechanotransduction. Its extended extracellular domain integrates multiple structural motifs that engage mechanical strain and ligand dependent cues at the cell surface and couples through the membrane to polycystin 2 (PC2), assembling a calcium permeable channel complex that localizes to primary cilia and apical membranes and converts luminal flow and shear stress into graded intracellular calcium signals. These PC1–PC2 dependent calcium fluxes intersect with calcineurin, mTORC1, ERK, and JAK–STAT pathways to modulate cell proliferation, differentiation, fluid secretion, and cytoskeletal remodeling, while PC1 simultaneously engages Wnt–planar cell polarity and integrin linked signaling to coordinate planar orientation of mitotic spindles, apicobasal polarization, and extracellular matrix organization across the tubular epithelium. In autosomal dominant polycystic kidney disease, germline or somatic inactivating PKD1 mutations impair PC1–PC2 complex formation, trafficking, or channel gating, leading to sustained suppression of calcium dependent growth inhibitory signals and aberrant activation of mTORC1 and proliferative kinase cascades that drive epithelial hyperplasia and misoriented divisions. This altered signaling environment promotes progressive tubular dilation, mislocalized fluid secretion, and matrix remodeling, resulting in cyst expansion in kidneys and liver, and analogous PC2 lesions produce a comparable phenotype, demonstrating the essential interdependence of both polycystins in maintaining tubular integrity, such that PC1 dependent signaling is ultimately dysregulated in the cystic epithelium.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください